Familial Glucocorticoid Deficiency: Advances in the Molecular Understanding of ACTH Action
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Familial glucocorticoid deficiency (FGD), otherwise known as hereditary unresponsiveness to ACTH, is a rare autosomal recessive disease characterized by glucocorticoid deficiency in the absence of mineralocorticoid deficiency. Mutations of the ACTH receptor, also known as the melanocortin-2 receptor (MC2R), account for approximately 25% of FGD cases. More recently a second gene, MRAP (melanocortin-2 receptor accessory protein), was identified and found to account for a further 15–20%. MRAP encodes a small single transmembrane domain protein, which is essential in the trafficking of the MC2R to the cell surface. In this review, we will firstly summarize the clinical presentation and genetic aetiology of this condition. Secondly, we will discuss how the discovery of MRAP has enhanced our understanding of the mechanisms of ACTH/MC2R action. Finally, we will explore future developments in this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134 · cited 1×
“but not all families segregate to chromosome 8 suggesting the involvement of additional genes. Receptor Accessory Proteins The discovery of MRAP has provided a new mechanism of melanocortin receptor regulation which was previously unknown. Small single transmembrane proteins such as the RAMPs, RTPs and REEPs are a gro…”
BackgroundThe cloning of a family of genes that encode the melanocortin receptors
Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., & Cone, R. D. (1992) · Science · doi:10.1126/science.1325670 · Cited by 1,635 · cited 1×
“Since then a large number of mutations have been found which are summarized in figure 1 . The ACTH receptor was the second melanocortin receptor to be cloned hence the alternative nomenclature of MC2R [”
BackgroundA frameshift mutation in MC4R associated with dominantly inherited human obesity
Yeo, G. S. H., Farooqi, I. S., Aminian, S., Halsall, D. J., Stanhope, R. G., & O'Rahilly, S. (1998) · Nature Genetics · doi:10.1038/2404 · Cited by 1,159
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509 · cited 1×
“P450 oxidoreductase deficiency in Antley-Bixler syndrome [”
Metherell, L. A., Chapple, J. P., Cooray, S., David, A., Becker, C., Rüschendorf, F., Naville, D., Begeot, M., Khoo, B., Nürnberg, P., et al. (2005) · Nature Genetics · doi:10.1038/ng1501 · Cited by 437 · cited 1×
“Homozygosity mapping, utilizing SNP (single nucleotide polymorphisms) microarrays across the whole genome, identified a third locus on chromosome 21 in some families with FGD. Fine mapping of the region together with mRNA expression studies of genes within this region revealed a candidate gene, now known as MRAP (mela…”
BackgroundSelf-citationAdrenocorticotropin insensitivity syndromes
Clark, A. J. L., & Weber, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0351 · Cited by 234 · cited 1×
“with permission]. F01 FGD is characterized by glucocorticoid deficiency in the presence of normal plasma renin and aldosterone levels. Nevertheless, mild derangements of the renin-angiotensin system at the time of diagnosis are sometimes seen with this condition [”
BackgroundSelf-citationTsigos, C., Arai, K., Hung, W., & Chrousos, G. P. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116853 · Cited by 182 · cited 1×
“in 1992 enabled researchers to identify point mutations in the ACTH receptor in patients with FGD [”
BackgroundNoon, L., Franklin, J., King, P., Goulding, N., Hunyady, L., & Clark, A. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1740017 · Cited by 88 · cited 1×
“and, in parallel with this, evidence accumulated of the existence of an ‘MC2R’ accessory factor [”
BackgroundSelf-citationInherited ACTH insensitivity illuminates the mechanisms of ACTH action
Clark, A. J. L., Metherell, L. A., Cheetham, M. E., & Huebner, A. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.10.006 · Cited by 82
Self-citationFlück, C. E., Martens, J. W. M., Conte, F. A., & Miller, W. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020501 · Cited by 57
Cited by
Ishimoto, H., & Jaffe, R. B. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0001 · Cited by 379
“the cell surface (248, 249), was identified, and mutations”
BackgroundFlück, C. E., Pandey, A. V., Dick, B., Camats, N., Fernández-Cancio, M., Clemente, M., Gussinyé, M., Carrascosa, A., Mullis, P. E., & Audi, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020178 · Cited by 94
“It appeared that StAR mutations with more than 10–20% of wt activity in vitro may rather manifest as NCLAH (or FGD) while an activity of less than 10% may be found with severe forms of CLAH.”
BackgroundInfluentialRhodes, M. E. (2017) · Stress: Neuroendocrinology and Neurobiology · doi:10.1016/b978-0-12-802175-0.00010-3 · Cited by 9
Metadata
- Authors
- Chan, L. F., Clark, A. J. L., & Metherell, L. A.
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2007-12-05
- Volume
- 69
- Issue
- 2
- Pages
- 75-82
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W2010478818
- Cited by
- 71
- References
- 10
- FWCI
- 3.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Familial Glucocorticoid Deficiency: Advances in the Molecular Understanding of ACTH Action. https://app.cochat.ai/papers/10.1159/000111810
- The paper
- Chan, L. F., Clark, A. J. L., & Metherell, L. A. (2008). Familial Glucocorticoid Deficiency: Advances in the Molecular Understanding of ACTH Action. Hormone Research in Paediatrics. https://doi.org/10.1159/000111810
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.